05:45 PM EDT, 03/19/2024 (MT Newswires) -- Moleculin Biotech ( MBRX ) said late Tuesday that its shares will start trading on a split-adjusted basis on March 22 following a 1-for-15 reverse stock split to regain compliance with Nasdaq's minimum bid price rules.

The number of shares outstanding will be reduced to about 2.2 million shares from around 33.4 million shares after the reverse stock split, the clinical-stage pharmaceutical company said.

Price: 0.55, Change: +0.03, Percent Change: +5.21